secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvus Pharmaceuticals, Inc. (CRVS)
CIK:        0001626971
Form:       8-K/A
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001171843-22-007083
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Corvus adopts annual advisory say-on-pay vote after stockholder vote
--------------------------------------------------------------------

- Board sets annual frequency for non-binding advisory votes on executive compensation.
- Policy effective until next required stockholder vote on frequency, no later than 2028 annual meeting.
- Decision follows stockholder advisory vote and board recommendation from June 2022 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626971/000117184322007083/0001171843-22-007083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626971/000117184322007083/f8ka_110322.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-007083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer